Skip to Content

Starpharma Holdings Ltd SPHRF Stock Quote

| Rating as of


Morningstar‘s Stock Analysis SPHRF

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics SPHRF

Company Profile SPHRF

Business Description

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.

4-6 Southampton Crescent, Abbotsford
Melbourne, VIC, 3067, Australia
T +61 385322700
Industry Biotechnology
Most Recent Earnings
Fiscal Year End Jun 30, 2023
Employees 32